Processa Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Processa Pharmaceuticals, Inc. on February 13, 2020. The company is incorporated in Delaware and operates as an emerging growth company. Its common stock trades on the OTC market under the symbol PCSA.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance rather than financial performance.
Material Changes
The primary material change reported is the appointment of Geraldine Pannu to the Company's Board of Directors, as announced in a press release dated February 13, 2020.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items. The document serves solely to disclose the board appointment.
Key Facts for Investor Verification
- Confirmation of Geraldine Pannu's appointment to the Board of Directors.
- Review of the full press release (Exhibit 99.1) for details on the new director's background.
- Verification of the company's status as an emerging growth company.